Cargando…
Inhibition of Zymosan-Induced Inflammatory Factors Expression by ATRA Nanostructured Lipid Carriers
Purpose. The study aimed to evaluate the effect of all-trans retinoic acid-loaded nanostructured lipid carriers (ATRA-NLCs) on the zymosan-induced expression of the cytokines IL-4, IL-10, and IFN-γ and the matrix metalloproteinases/tissue inhibitor of metalloproteinases (MMPs/TIMPs) and TLR(2) in ra...
Autores principales: | Zhou, Hongyan, Zhang, Wensong, Gao, Xunyi, Zhang, Hongguang, Kong, Ning |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4908262/ https://www.ncbi.nlm.nih.gov/pubmed/27340562 http://dx.doi.org/10.1155/2016/4952340 |
Ejemplares similares
-
Antineoplastics Encapsulated in Nanostructured Lipid Carriers
por: Rodrigues da Silva, Gustavo Henrique, et al.
Publicado: (2021) -
The mechanism for the radioprotective effects of zymosan‐A in mice
por: Du, Jicong, et al.
Publicado: (2018) -
Inhibition of zymosan-induced kidney dysfunction by tyrphostin AG-490
por: Dimitrova, Petya, et al.
Publicado: (2009) -
Transferrin-modified nanostructured lipid carriers as multifunctional nanomedicine for codelivery of DNA and doxorubicin
por: Han, Yiqun, et al.
Publicado: (2014) -
Improvement of oral bioavailability of lovastatin by using nanostructured lipid carriers
por: Zhou, Jun, et al.
Publicado: (2015)